Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified

Techne

(

TECH

) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Techne as such a stock due to the following factors:

  • TECH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $22.9 million.
  • TECH is making at least a new 3-day high.
  • TECH has a PE ratio of 30.2.
  • TECH is mentioned 1.55 times per day on StockTwits.
  • TECH has not yet been mentioned on StockTwits today.
  • TECH is currently in the upper 20% of its 1-year range.
  • TECH is in the upper 35% of its 20-day range.
  • TECH is in the upper 45% of its 5-day range.
  • TECH is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in TECH with the Ticky from Trade-Ideas. See the FREE profile for TECH NOW at Trade-Ideas

More details on TECH:

Bio-Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. The stock currently has a dividend yield of 1.4%. TECH has a PE ratio of 30.2.

The average volume for Techne has been 194,600 shares per day over the past 30 days. Techne has a market cap of $3.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.51 and a short float of 5.2% with 8.40 days to cover. Shares are down 4.2% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null